IRIDEX CEO and President Will Moore believes these sales are due in part to a shift in the ophthalmology market from drug-based treatments towards laser-based treatments.
More Articles on Ophthalmology:
InSite Vision to Present at ARVO 2013
Glaucoma Management Lens to be Presented at ARVO 2013
3 Statistics on Cataract Surgery Procedure Times in ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
